VENUS REMEDIES Share Price

VENUS REMEDIES Share Price

NSE: VENUSREM
|
Pharmaceuticals
|
S Cap
₹ 1,657.10
-₹37.30 (-2.2%)
1D
Last updated 07 Sep, 2026, 15:29 IST

VENUS REMEDIES Share Price Today

As of 7 Sep 2026, VENUS REMEDIES share price is ₹1,657.10. The stock opened at ₹1,694.40, compared to its previous close of ₹1,694.40. During today's trading session, VENUS REMEDIES share price moved in the range of ₹1,652.10 to ₹1,724.90, with an average price of ₹1,688.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹424.00 and a high of ₹2,044.30. On the performance front, VENUS REMEDIES share price has increased by 150.91% over the last six months and is up 265.33% on a year-on-year basis.

₹1,652.10
2.20% down today
₹1,724.90
1D LOW
1D HIGH

VENUS REMEDIES Returns Calculator

Circuit
L
H
₹1,609.70
₹1,779.10
52-week
L
H
₹424.00
₹2,044.30

About VENUS REMEDIES

VENUS REMEDIES Share Price
ISIN
INE411B01019
Sector Market Cap
₹ 2,258.02 Cr

Venus Remedies Limited is a research-driven pharmaceutical company. The Company is a global injectable manufacturer. It manufactures products catering to critical care segments such as antimicrobial resistance, anti-cancer, Anti-infective, Neurology, Skin and Wound Care, and Pain Management. With a diverse portfolio of products, the Company is dedicated to revolutionizing patient care through its specialized therapeutic segments such as anti-infective (antibiotics), oncology, neurology, pain management, and skin & wound care. The Company operates only in one business segment: Pharmaceutical Formulation and is engaged in manufacturing and trading of medicines. Its focus therapy areas include medicine, surgery, neuro and orthopedics. The Company’s brands include Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, and others. It has three manufacturing facilities: Panchkula and Baddi in India and Werne in Germany.

VENUS REMEDIES Financial Highlights

  • Revenue: VENUS REMEDIES reported revenue of ₹782.18 crore in FY26 vs ₹668.84 crore in FY25. It showed an increase of 16.95% on a yearly basis.
  • Operating Profit: VENUS REMEDIES reported an operating profit of ₹134.16 crore in FY26 vs ₹71.82 crore in FY25. It showed an increase of 86.80% on a year-on-year basis.
  • Net Profit: VENUS REMEDIES reported a net profit of ₹102.79 crore in FY26 vs ₹45.32 crore in FY25. It showed an increase of 126.81% on a yearly basis.

VENUS REMEDIES Quarterly Result Highlights

  • VENUS REMEDIES reported revenue of ₹181.48 crore in Jun 2026, compared with ₹264.35 crore in Mar 2026, representing a decrease of 31.35% on a quarter-on-quarter (QoQ) basis.
  • VENUS REMEDIES reported an operating profit of ₹30.04 crore in Jun 2026, compared with ₹61.61 crore in Mar 2026, representing a decrease of 51.24% on a quarter-on-quarter (QoQ) basis.
  • VENUS REMEDIES reported a profit of ₹22.97 crore in Jun 2026, compared with ₹47.50 crore in Mar 2026, reflecting a decrease of 51.64% on a QoQ basis.
  • The earnings per share (EPS) of VENUS REMEDIES stood at ₹33.90 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
41.76%
FII
2.92%
Other DII
0.89%
Retail and other
54.43%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20251.86%
Dec 20252.26%
Mar 20262.80%
Jun 20262.92%
Mkt Cap Cr
2,258.02
P/E
19.43
P/B
3.40
ROE
15.49%
D/E
0.02
ROCE
19.85%
Div. Yield
0.59%
EPS(TTM)
74.29
Turnover
0.93
EV/EBITDA
12.64
Net Margin
0.00%
Op. Margin
0.00%
ROA
13.61%
Quick Ratio
0.00
Curr. Ratio
2.59
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Venus Remedies outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Venus Remedies appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Venus Remedies earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,55,634.0037.605.4513.74%0.6117.33%93.240.84%0.4810.90
Divis Laboratories2,41,576.0082.5914.4115.32%0.0019.56%629.490.33%0.5598.19
Torrent Pharmaceuticals1,84,478.0085.5721.9425.49%1.6913.85%222.760.70%0.4958.70
Cipla1,11,888.0033.343.2511.27%0.0014.95%423.360.94%0.4543.52
Zydus Lifesciences1,11,820.0024.354.1218.59%0.3117.35%237.300.09%0.3335.38
Laurus Labs99,417.5091.1818.7616.77%0.4016.14%97.200.11%0.6713.72
Lupin96,528.8017.394.3023.76%0.0424.88%659.000.85%0.57129.18
Dr. Reddy's Laboratories96,322.1030.262.5311.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma96,179.6046.525.9011.74%0.3413.13%396.980.04%0.4449.37
Aurobindo Pharma95,127.2025.642.519.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

VENUS REMEDIES Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹647.89₹601.45₹555.51₹600.18
Other Income₹20.96₹11.58₹10.32₹8.31
Total Revenue₹668.84₹613.03₹565.83₹608.49
Total Expenses₹606.93₹568.39₹527.90₹572.08
Profit Before Tax₹71.83₹44.64₹37.93₹36.41
Tax₹26.51₹16.15₹11.36-₹4.32
Profit After Tax₹45.31₹28.49₹26.57₹40.72
EPS - Basic₹33.90₹21.31₹19.88₹30.86
EPS - Diluted₹33.90₹21.31₹19.88₹30.86

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹61.87₹44.64₹37.93₹36.41
Income before WC changes₹76.83₹64.88₹61.26₹62.74
Change in Assets₹10.91-₹45.64-₹86.18-₹56.21
Change in Liabilities₹13.62₹33.53₹61.55₹34.57
Change in WC₹24.53-₹12.11-₹24.63-₹21.64
Cash flow from Operations₹86.44₹37.29₹36.63₹41.10
Cash flow from Investing-₹76.25-₹7.21-₹50.83-₹16.73
Cash flow from Financing-₹1.02-₹1.08-₹0.57-₹9.48
Total Cash Flow₹9.18₹28.99-₹14.77₹14.90
Cash (Start of the year)₹48.96₹21.21₹43.26₹28.88
Cash (End of the year)₹57.52₹48.96₹21.21₹43.26

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹264.00₹267.30₹278.25₹301.78
Current Assets₹451.72₹359.52₹322.84₹278.04
Total Assets₹715.72₹626.82₹601.08₹579.82
Current Liabilities₹136.29₹79.42₹82.57₹92.74
Net Current Asset₹315.43₹280.11₹240.26₹185.30
Non-Current Liabilities₹18.48₹59.86₹58.17₹46.63
Equity Capital₹560.95₹487.55₹460.34₹440.45
Total Equity & Liabilities₹715.72₹626.82₹601.08₹579.82

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹639.46₹575.21₹537.66₹576.71
Other Income₹20.78₹11.32₹10.17₹8.43
Total Revenue₹660.24₹586.53₹547.84₹585.14
Total Expenses₹591.08₹539.88₹507.51₹540.47
Profit Before Tax₹79.08₹46.65₹40.33₹44.67
Tax₹26.51₹16.15₹11.36-₹4.32
Profit After Tax₹52.56₹30.50₹28.96₹48.99
EPS - Basic₹39.32₹22.82₹21.67₹37.12
EPS - Diluted₹39.32₹22.82₹21.67₹37.12

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹69.16₹46.65₹40.33₹44.67
Income before WC changes₹83.17₹66.01₹62.58₹69.50
Change in Assets-₹5.74-₹16.70-₹24.98-₹24.12
Change in Liabilities₹20.59₹1.56-₹9.55-₹4.38
Change in WC₹14.86-₹15.15-₹34.53-₹28.50
Cash flow from Operations₹83.10₹35.38₹28.05₹41.00
Cash flow from Investing-₹76.20-₹6.94-₹50.81-₹16.75
Cash flow from Financing₹0.00₹0.00₹0.00-₹9.13
Total Cash Flow₹6.90₹28.44-₹22.76₹15.12
Cash (Start of the year)₹48.51₹20.07₹42.83₹27.70
Cash (End of the year)₹55.41₹48.51₹20.07₹42.83

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹277.46₹280.26₹290.70₹314.25
Current Assets₹435.75₹361.00₹318.19₹264.41
Total Assets₹713.21₹641.26₹608.89₹578.66
Current Liabilities₹105.23₹72.81₹72.67₹82.61
Net Current Asset₹330.51₹288.18₹245.53₹181.80
Non-Current Liabilities₹18.48₹59.86₹58.17₹46.63
Equity Capital₹589.49₹508.59₹478.05₹449.41
Total Equity & Liabilities₹713.21₹641.26₹608.89₹578.66
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
53.06
Neutral
ATR (14)
79.79
Neutral
STOCH(9,6)
62.93
Neutral
STOCH RSI (14)
48.25
Neutral
ADX(9)
21.54
Bearish
UO(9)
56.94
Neutral
ROC(12)
-4.26
Bearish
WillR(14)
-50.72
Neutral
Period
Simple value
Exponential vaue
5D
1656.34
1666.9
10D
1645.77
1663.43
20D
1680.19
1664.61
50D
1685.4
1629.61
100D
1477.89
1485.94
Volume trend — traded volume by day
7 Sep0L
4 Sep0L
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
VENUS REMEDIES Share Price
VENUS REMEDIES
Pharmaceuticals
Add Stock
Add Another

VENUS REMEDIES Share Price FAQs

VENUS REMEDIES share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837